戻る Agendas
PRIMARY FACTORS FOR TRIAL LOCATION
Session Chair(s)
Dorthe Poulsen, LLM
Eu-coordinator and chief legal adviser
Danish Health and Medicines Authority, Denmark
Which factors are decisive for the decision to conduct a clinical trial in a certain part of the world? There is no doubt that the EU competes with other parts of the world such as the BRIC countries. In this session, we’ll have a look at the EU in a more global context. Case stories are welcomed as this would be illustrative for participants.
Speaker(s)
Country Allocation in Global Perspective
Henrik Troelsen
Novo Nordisk, Denmark
Director, Global Trial Allocation
The Swedish Way to Foster Innovation
Christer Backman, LLM
Medical Products Agency, Sweden
International Coordinator & Senior Expert
Japanese Policy & Japanese Trial Sites
Toshiyoshi Tominaga, PHD
SunFlare Co., Ltd, Japan
Life Science Department, Advisor